The unified social credit code/registration number of Chengyu Group Shaanxi Yafukang Pharmaceutical Co., Ltd. is 9161010429 4392563q, and the enterprise is in the opening state.
The business scope of Chengyu Group Shaanxi Yafukang Pharmaceutical Co., Ltd. is: Chinese patent medicines, Chinese herbal medicines, Chinese herbal pieces, biochemical medicines, biological products (except vaccines), chemical pharmaceutical preparations, antibiotic preparations, antibiotic raw materials, psychotropic drugs of category II, protein assimilation preparations, peptide hormones, medical devices of category I, II and III, disinfection products, prepackaged foods (excluding frozen food) and medical care. Sales of infant formula milk powder, other infant formula foods, cosmetics, health products, daily chemicals, labor insurance supplies, family planning supplies, chemical raw materials and products (excluding inflammable and explosive dangerous chemicals), medical packaging materials, pharmaceutical excipients and chemical reagents (except dangerous goods); General cargo transportation: warehousing (excluding inflammable and explosive dangerous goods), distribution and freight forwarding; Manufacture and sale of hot food; Business information consultation; Conference services; Exhibition service; Logistics information consultation; Supply chain management; Quality management system certification consulting; Enterprise staff training. (If the above business scope involves licensed projects, it shall be operated within the validity period with the license certificate or approval certificate, and shall not be operated without permission). In Shaanxi Province, the total registered capital of companies with similar business scope is 6.5438+066328 million yuan, and the main capital is concentrated in 6.5438+0000-50 million and 6.5438+0000-65438+0000 million enterprises and 350 enterprises. In the province, the registered capital of enterprises is excellent.
See more information and materials of Chengdu-Chongqing Group Shaanxi Yafukang Pharmaceutical Co., Ltd. through Baidu Enterprise Credit.